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Introduction 
Nature’s ability to perform cascade reactions in an effective way is 
based on the correct assembly of the different biocatalysts in a metabolon. 
Positional control is especially important in multistep reactions, in which the 
product of one catalytic reaction is used directly as substrate for the next 
transformation. Immobilization of catalysts, e.g. adsorption of enzymes on 
beads or homogeneous catalysts on solid supports has been a topic of 
investigation for many years.1 Compared to nature’s metabolons, not much 
control over the spatial distribution of the catalytic sites in these manmade 
supported catalysts is obtained. In order to have more control new methods for 
catalyst assembly have to be developed. This can be achieved by using 
Nature’s approach of organization through self assembly. To imitate this we 
are looking for ways to assemble enzymes on a supramolecular support to 
produce a synthetic metabolon. Next to enzymes these metabolons can contain 
non-biological catalysts.  
In a model system we are engineering a lipase to introduce chemical 
handles for covalent immobilization. The lipase explored for this procedure is 
the lipase Candida Antarctica Lipase B (CAL-B). CAL-B is a very stable 
enzyme, which can tolerate high temperatures and a variety of solvents 
without losing activity. We will introduce a chemical functionality through 
incorporation of a non-natural amino acid functioning as a handle for covalent 
attachment to a scaffold. Using protein engineering it has been shown that the 
methionine analogues like azidohomoalanine or homo propargyl glycine can 
be readily incorporated into proteins using a bacterial auxotroph strain.2 After 
introduction of an azido function a covalent connection between enzyme and 
molecules containing a terminal acetylene function can be made by a Cu-
catalyzed Huisgen [3+2] cycloaddition.3
Virus particles such as Cowpea chlorotic mottle virus and Potatoe virus 
X (PVX) are excellent examples of well-defined non-covalent assemblies. The 
protein shells of viruses provide highly promising scaffolds for the 
construction of new materials.4 In addition to possessing nano-scale 
dimensions overall, the protein subunits that comprise the capsid shell present 
regularly spaced attachment sites that could order different material 
compounds.4f,5 It can be envisaged that the capsid proteins can be covalently 
functionalized via protein engineering with bio active proteins such as 
enzymes. Like this we can develop a catalyst scaffold based on a virus 
particle, which will enable us to gain control over catalyst organization via 
assembly of the support (fig.1). A significant practical advantage is the ease 
with which large quantities of the catalytically active particles can be obtained 
due to the reproductive power of viruses, thus giving rise to a one step 
production method for biocatalyst and scaffold.  
  
Figure 1. Schematic representation of enzyme decorated virus particle.  
A second self assembling scaffold can be developed using the 
organization properties of surfactant molecules into highly ordered structures, 
such as rods, ribbons, tubes and helices.6 The introduction of strong hydrogen 
bonding moieties has been shown to be instrumental in the structuring and 
stabilization of such assemblies. The incorporation of bis-ureido groups in 
molecules and polymers gives rise to strong hydrogen bonding interactions 
that have been used to form stable organo- 7, and hydro-gels 8, to structure 
inorganic materials 9, and also polymeric assemblies. We are going to use an 
an ammonium terminated surfactant, in which a bis-ureido group is 
incorporated in its hydrocarbon chain.10 This molecule forms well-defined 
highly ordered ribbon-like bilayer aggregates in water. In addition it has been 
demonstrated that these ribbons can be functionalized via a modular approach 
through molecular recognition of other bis-urea containing molecules.10 Such 
molecules can be linked to enzymes which can than be ordered through 
assembly of the support.  
Here we report on our progress in developing the different scaffolds for 
enzyme immobilization and in producing a modified enzyme that can be 
attached to these scaffolds. 
 
Results and Discussion 
 
We have produced fusion proteins of PVX capsids with CAL-B. Using 
molecular biology techniques we have fused the genes encoding the two 
proteins. In order to prevent steric hindrance of the bulky enzyme during the 
capsid assembly process the genetic construct was made in such a way that 
partly the fusion protein and partly the capsid alone was produced. Virus 
particles produced by plants that were infected with modified viral RNA were 
decorated with CAL-B (see fig.1), as could be observed by electron 
microscopy and Western blotting. Unfortunately expressing the fusion protein 
appeared to be toxic to the plant and this led to a very low amount of virus 
particles that could be isolated. 
In conclusion, our system to produce in one step a catalytically active 
virus particle works. However the yield is very low. We are now investigating 
other methods to immobilize enzymes on the virus particle after virus 
production. 
 
Figure 2. TEM image of ribbons. a. schematic structure of ammonium 
terminated surfactant. b. molecular model of the ribbon. c. TEM image 
of ribbons. 
As a second self assembling scaffold we are using an ammonium 
terminated surfactant containing a bis-ureido group.10 Extensive studies on the 
aggregation behavior of these ribbon aggregates, performed in Eindhoven, led 
to a model for the molecular arrangement within the aggregate, in which the 
surfactant molecules form a fully interdigitated bi-layer. The ribbons can be 
functionalized by incorporating other bis-ureido-butylene modified molecules. 
Functionalization of these ribbons with molecules of biological origin was 
demonstrated by coupling biotin to a ureido-butylene moiety via a PEG 
spacer. This molecule can be incorporated into the ribbons and incubation 
with gold-labeled streptavidin led to selective decoration of the ribbons with 
these biomacromolecules10. 
We can bio functionalize the ribbons after their formation. We are now 
developing ways to insert molecules that will lead to chemical functionalities 
on the surface of the ribbons that will allow us to attach enzymes in a bio 
orthogonal fashion.  
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Figure 3. Purification and activity of recombinant CAL-B. a. Total protein 
stain (silver stain) of poly acrylamide gel electrophoresis analysis of 
His6 tag purification of CAL-B. E=extract, FT= flow through, w=wash, 
e=elution fraction. b. structure of Tween 80. c. CAL-B activity assay. 
The bio orthogonal reaction that we are going to use is the Cu-catalyzed 
Huisgen [3+2] cycloaddition. For this we need to engineer enzymes to contain 
either an azide or acetylene functionality. To do this for our model enzyme we 
have to express the enzyme in a bacterial system. For this we isolated the gene 
encoding CAL-B from the yeast Pseudozyme aphidis using a PCR method. 
We cloned the gene into the bacterial expression vector pET22B in which the 
gene is couples to a tag of 6 histidines at the C-terminus. The protein was 
expressed and purified using Ni-NTA column chromatography (fig. 3a). The 
contaminating proteins in the elution fractions could be removed by size 
exclusion chromatography. We tested the fractions for esterase activity by 
spotting the fractions on agar plate containing Tween 80, which is a substrate 
for CAL-B. After hydrolysis of this molecule by the enzyme a white 
precipitate is formed which is visible on the plate. We found that the purified 
protein indeed has esterase activity (fig 3).  
We are now able to produce and purify active CAL-B in a bacterial 
system. We transformed a methionine auxotrophe strain with our CAL-B 
expression vector in order to produce the enzyme with incorporated 
methionine analogs. CAL-B contains four internal methionines. On a small 
scale we have been able to produce the enzyme in the presence of 
azidohomoalanine. In a test reaction we have performed a Cu-catalyzed 
cycloaddition in the presence of an alkynyl functionalized poly ethylene 
glycol (PEG, Mw=2000 Da). After analysis it using Western blotting it 
appeared that azidohomo alanine was introduced and that one was available 
for reaction. We can produce CAL-B containing azide functionalities that can 
be modified by a Cu-catalyzed cycloaddition in the presence of an acetylene 
containing reactant. This sets the stage for being able to covalently attach 
CAL-B to a scaffold that is functionalized with an acetylene moiety. 
 
Conclusions 
We have shown that we can produce enzyme coated virus particles in a 
one step procedure. However the yields are very low. We are investigating 
other methods to immobilize enzymes to viruses either covalently or non 
covalently. We have made progress in developing a different scaffold for 
enzyme immobilization by using an ammonium terminated surfactant, in 
which a bis-ureido group is incorporated in its hydrocarbon chain. We have 
shown that aggregates formed by this amphiphilic molecule can be bio 
functionalized. Progress is made by engineering our model enzyme into 
harboring functionalities that can be used to covalently link the enzyme to 
other structures in a bio orthogonal manner.  
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